Activity of Amikacin, Gentamicin and Schering 21420 when Combined with Carbenicillin or Piperacillin against Pseudomonas aeruginosa
Authors:
- Frank SchaferFSFrank Schafer
- Carl W. NordenCNCarl W. Norden
- 1 January 1982
- journal article
- research article
- Published by S. Karger AG in Chemotherapy
- Vol. 28 (4) , 253-256
Abstract
The in vitro activities of three aminoglycosides [Schering 21420 (a 1N-HAPA derivative of gentamicin B), amikacin and gentamicin] plus carbenicillin or piperacillin were tested against 16 clinical isolates of Pseudomonas aeruginosa. Piperacillin, when combined with any of the three aminoglycosides, demonstrated synergy significantly more frequently than carbenicillin plus these same aminoglycosides.Keywords
This publication has 6 references indexed in Scilit:
- Comparison of Techniques for Measurement of in Vitro Antibiotic SynergismThe Journal of Infectious Diseases, 1979
- Analysis of the Interactions Between Piperacillin, Ticarcillin, or Carbenicillin and Aminoglycoside AntibioticsAntimicrobial Agents and Chemotherapy, 1978
- Piperacillin: In Vitro EvaluationAntimicrobial Agents and Chemotherapy, 1978
- In Vitro Studies of Piperacillin, a New Semisynthetic PenicillinAntimicrobial Agents and Chemotherapy, 1978
- 1-N HAPA gentamicin B,a new aminoglycoside active against gentamicin resistant isolates - activity compared to other aminoglycosides.The Journal of Antibiotics, 1978
- Biological activity of Sch 21420, the 1-N-S-.ALPHA.-hydroxy-.BETA.-aminopropionyl derivative of gentamicin B.The Journal of Antibiotics, 1978